» Articles » PMID: 2164042

The Tumor Necrosis Factor Receptor and Human Neutrophil Function. Deactivation and Cross-deactivation of Tumor Necrosis Factor-induced Neutrophil Responses by Receptor Down-regulation

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1990 Jul 1
PMID 2164042
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Despite numerous reports, the role of tumor necrosis factor (TNF) in polymorphonuclear leukocyte (PMN) function remains controversial. We found TNF to be a potent, pertussis toxin-independent stimulator of PMN adhesion (ED50 2.6 pM). TNF-stimulated PMN under adherent conditions released up to 65% of their transcobalamine content (ED50 3.9 pM) and increased their burst activity 10-fold (ED50 3.2 pM) as measured by the hexose monophosphate shunt, whereas PMN held in suspension hardly degranulated at all and only little burst activity was demonstrable. However, preincubation of PMN with TNF in suspension led to a decrease in cellular adhesiveness, degranulation, and burst activity in response to a secondary stimulus of TNF under adherent conditions, although cells remained fully responsive toward phorbol myristate acetate. A concomitant dose-dependent decline of TNF receptor numbers that correlated well with the inhibition of PMN function (r = 0.91) suggests receptor down-regulation as the mechanism of functional PMN deactivation. Remarkably, preincubation with other PMN stimuli such as N-formyl-methionyl-leucyl-phenylalanine, platelet-activating factor, leukotriene B4, complement component fragment 5a (C5a)/C5a (desarginated), and endotoxin also led to a reduction of TNF-specific PMN responses (cross-deactivation) from 35% (LTB4) to 90% (endotoxin), corresponding with the down-regulation of TNF receptors. Deactivation and receptor down-regulation are independent of pertussis toxin-sensitive G proteins and protein kinase C but seemed to depend on changes in calcium metabolism. Granulocyte hyporesponsiveness towards TNF in sepsis (with elevated blood levels of endotoxin and TNF) might be a mechanism of self-protection or, to the contrary, might impair a possibly central mode of host defense.

Citing Articles

Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.

Bertok S, Wilson M, Dorr A, Dokpesi J, ODea K, Marczin N Am J Physiol Lung Cell Mol Physiol. 2011; 300(5):L781-9.

PMID: 21378027 PMC: 3094030. DOI: 10.1152/ajplung.00326.2010.


Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.

Deng X, Luyendyk J, Ganey P, Roth R Pharmacol Rev. 2009; 61(3):262-82.

PMID: 19805476 PMC: 2763781. DOI: 10.1124/pr.109.001727.


Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines.

Fumeaux T, Dufour J, Stern S, Pugin J Intensive Care Med. 2004; 30(11):2028-37.

PMID: 15368036 DOI: 10.1007/s00134-004-2429-8.


Regulation of serum amyloid A protein expression during the acute-phase response.

Jensen L, WHITEHEAD A Biochem J. 1998; 334 ( Pt 3):489-503.

PMID: 9729453 PMC: 1219714. DOI: 10.1042/bj3340489.


Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients.

Kowanko I, Ferrante A, Clemente G, Youssef P, Smith M J Clin Immunol. 1996; 16(4):216-21.

PMID: 8840223 DOI: 10.1007/BF01541227.


References
1.
Atkinson Y, Marasco W, Lopez A, Vadas M . Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest. 1988; 81(3):759-65. PMC: 442523. DOI: 10.1172/JCI113381. View

2.
Smith C, Rothlein R, Hughes B, Mariscalco M, Rudloff H, Schmalstieg F . Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest. 1988; 82(5):1746-56. PMC: 442745. DOI: 10.1172/JCI113788. View

3.
Becker E, Showell H, Henson P, Hsu L . The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J Immunol. 1974; 112(6):2047-54. View

4.
Cuatrecasas P, Hollenberg M . Membrane receptors and hormone action. Adv Protein Chem. 1976; 30:251-451. DOI: 10.1016/s0065-3233(08)60481-7. View

5.
Fernandez H, Hugli T . Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol. 1976; 117(5 Pt 1):1688-94. View